1

PUBLIC HEALTH NEEDS MORE THAN A TEST RESULT.

A NEGATIVE TEST IS ONLY AS RELIABLE AS THE SPECIMEN BEHIND IT.

 

When substitution rises, collection alone is not enough.
RUMA adds the verification layer.
Across U.S. drug testing, published workforce data show a sharp rise in specimen substitution and invalid specimens.
Traditional collection controls focus on the moment of collection.

RUMA verifies the entire chain.

Person → Unique one time Marker → Specimen → Laboratory → Verified Result

The challenge is not limited to the workplace. Wherever drug testing informs treatment, compliance, public safety or institutional decisions, specimen attribution matters.

RUMA adds a verification layer for public-health applications where manipulation resistance, reliable person-to-specimen attribution, privacy, laboratory confirmation and documented processes are essential.

Already evaluated and implemented in Germany’s public-health system.

Verify the chain. Not just the collection.

RUMA adds the missing verification layer:
 

  • Verified person-to-specimen attribution
  • Manipulation-resistant urine testing
  • Random, unannounced testing
  • Documented digital process
  • Independent laboratory confirmation
  • Privacy-preserving workflows
  • Remote and decentralized implementation
  • Auditable results across multiple public-health settings

Not just for addiction medicine.

 

RUMA can support drug-testing workflows wherever public health needs reliable evidence — from behavioral health and community programs to occupational health, public institutions, prevention programs and other regulated care settings.

BUILT TO INTEGRATE. NOT TO DISRUPT.

RUMA Digital-System (Pro) adds a verification layer to existing healthcare, laboratory and compliance structures.

  • No replacement of established workflows.
  • No new infrastructure required.
  • Verification where it matters.
For U.S. healthcare systems, that means a solution designed to strengthen existing processes — not rebuild them.
RUMA has already been evaluated within Germany’s regulated healthcare environment and implemented within existing structures.
Already proven in a regulated healthcare market.
 

Built for U.S. integration and scale.

REGULATORY CLARITY. FASTER IMPLEMENTATION.

New verification technology does not have to mean new regulatory infrastructure.

RUMA was reviewed and confirmed as usable within existing structures.

  • Regulatory requirements reviewed
  • Existing legal basis confirmed
  • No new administrative regulation required
  • Implementation within existing healthcare structures possible

For U.S. healthcare systems, the principle matters:

Innovation becomes scalable when it can integrate into existing clinical, laboratory and compliance structures — instead of forcing organizations to rebuild them.

Add verification. Not bureaucracy.

Less supervision. More lawful self-management. Full verification.

LAWFUL SELF-MANAGEMENT. VERIFIED.

 

Community supervision should not create permanent dependence on control.
It should strengthen the ability to meet legal obligations independently.

RUMA supports lawful self-management by transferring responsibility for the testing process back to the person under supervision — while keeping compliance verifiable.

  • Independent fulfillment of testing requirements
  • Random, unannounced testing
  • Verifiable compliance with court-ordered conditions
  • More personal responsibility
  • Less dependence on fixed control appointments
  • More time for counseling, support and reintegration
  • Documented, reviewable results

PROVEN IN GERMANY

Reviewed by the German Ministry of Justice.

Data-security requirements verified.

Approved for nationwide use in probation services since March 2026.

Information security certified to ISO/IEC 27001.

RUMA combines personal responsibility with verifiable compliance.

Responsibility moves to the participant.
Verification remains with the system.

EMPOWER PATIENTS. STRENGTHEN TREATMENT.

RUMA shifts part of the responsibility back to the patient — while keeping the process verifiable.

Aligned with WHO priorities: engaging and empowering people and supporting self-management.

WHO – Integrated people-centred care

That supports a more active role in treatment and can strengthen:
  • Patient empowerment
  • Self-efficacy
  • Adherence
  • Trust in the therapeutic relationship
  • Privacy and dignity
  • Integration into everyday life
  • Less stress around testing
  • More time for actual treatment

RUMA translates that principle into the drug-testing process:

The patient takes responsibility.
The provider keeps verification.

Evidence-based and already in clinical use.